[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  quantumup [@Quantumup1](/creator/twitter/Quantumup1) on x 3534 followers Created: 2025-07-18 11:05:09 UTC Citizens reiterated $ABVX at a Market Outperform rating, a $XX PT and a High-Conviction name after its confidence in the pot'l for +VE obefazimod Ph3 results in moderate-to-severe ulcerative colitis were reinforced by its #KOL call" $PTGX - $JNJ $VTYX $LLY $PFE Citizens added, "On Wednesday, we hosted Dr. Marla Dubinsky, a gastroenterologist at Mt. Sinai and an IBD #KOL, for a discussion on the upcoming Phase X results for obefazimod in ulcerative colitis. Dr. Dubinsky is encouraged about the potential for positive results for obefazimod in moderate-to-severe ulcerative colitis due to the positive Phase 2b results, especially the clear improvement in endoscopy scores and benefit in highly refractory patients. $ABVX is one of our two high-conviction names into Phase X results that are coming soon." XXXXX engagements  **Related Topics** [$mrk](/topic/$mrk) [op](/topic/op) [$lly](/topic/$lly) [$vtyx](/topic/$vtyx) [$jnj](/topic/$jnj) [$abvx](/topic/$abvx) [$ptgx](/topic/$ptgx) [johnson johnson](/topic/johnson-johnson) [Post Link](https://x.com/Quantumup1/status/1946164333257404463)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
quantumup @Quantumup1 on x 3534 followers
Created: 2025-07-18 11:05:09 UTC
Citizens reiterated $ABVX at a Market Outperform rating, a $XX PT and a High-Conviction name after its confidence in the pot'l for +VE obefazimod Ph3 results in moderate-to-severe ulcerative colitis were reinforced by its #KOL call" $PTGX - $JNJ $VTYX $LLY $PFE Citizens added, "On Wednesday, we hosted Dr. Marla Dubinsky, a gastroenterologist at Mt. Sinai and an IBD #KOL, for a discussion on the upcoming Phase X results for obefazimod in ulcerative colitis.
Dr. Dubinsky is encouraged about the potential for positive results for obefazimod in moderate-to-severe ulcerative colitis due to the positive Phase 2b results, especially the clear improvement in endoscopy scores and benefit in highly refractory patients.
$ABVX is one of our two high-conviction names into Phase X results that are coming soon."
XXXXX engagements
Related Topics $mrk op $lly $vtyx $jnj $abvx $ptgx johnson johnson
/post/tweet::1946164333257404463